Literature DB >> 19471098

Ionic mechanisms underlying action potential prolongation by focal cerebral ischemia in rat ventricular myocytes.

Ling Wang1, Lihua Sun, Yanli Zhang, Huiwei Wu, Chao Li, Zhenwei Pan, Yanjie Lu, Baofeng Yang.   

Abstract

Despite prolongation of the QTc interval in humans during cerebral ischemia, little is known about the mechanisms that underlie these actions. Cerebral ischemic model was established by middle cerebral artery occlusion (MCAO) for 24 h. In rat ventricular myocytes, the effect of cerebral ischemia on action potential duration (APD) and underlying electrophysiologic mechanisms were investigated by whole-cell patch clamp. We demonstrated that heart rate-corrected QT interval and APD were prolonged with frequent occurrence of ventricular tachyarrhythmias in a rat model of MCAO. The I(Na) density was overall smaller in cerebral ischemic myocytes relative to sham myocytes (P < 0.01). The Nav1.5 protein and mRNA levels (pore-forming subunit for I(Na) ) were decreased by about 20% (P < 0.01) in cerebral ischemic rat hearts than those in sham-operated rat hearts. Peak transient outward K(+) current (I(to)) at +60 mV was found decreased by approximately 32.3% (P < 0.01) in cerebral ischemic rats. The peak amplitude of L-type Ca(2+) current (I(Ca,L)) was increased and the inactivation kinetics were slowed (P < 0.01). Protein level of the pore-forming subunit for I(to) was decreased, but that for I(Ca,L) was increased. The inward rectifier K(+) current (I(K1)) at -120 mV and its protein level were unaffected. Our study represents the first documentation of I(Na), I(to) and I(Ca,L) channelopathy as the major ionic mechanism for cerebral ischemic QT prolongation. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471098     DOI: 10.1159/000218177

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Macrophage-NLRP3 Inflammasome Activation Exacerbates Cardiac Dysfunction after Ischemic Stroke in a Mouse Model of Diabetes.

Authors:  Hong-Bin Lin; Guan-Shan Wei; Feng-Xian Li; Wen-Jing Guo; Pu Hong; Ya-Qian Weng; Qian-Qian Zhang; Shi-Yuan Xu; Wen-Bin Liang; Zhi-Jian You; Hong-Fei Zhang
Journal:  Neurosci Bull       Date:  2020-07-18       Impact factor: 5.203

2.  Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients.

Authors:  Vincenzo Russo; Andreina Carbone; Filiberto Fausto Mottola; Rosa Mocerino; Raffaele Verde; Emilio Attena; Nicoletta Verde; Pierpaolo Di Micco; Luigi Nunziata; Francesco Santelli; Gerardo Nigro; Sergio Severino
Journal:  Front Pharmacol       Date:  2020-10-08       Impact factor: 5.810

3.  Modulating cardiac conduction during metabolic ischemia with perfusate sodium and calcium in guinea pig hearts.

Authors:  Sharon A George; Gregory Hoeker; Patrick J Calhoun; Michael Entz; Tristan B Raisch; D Ryan King; Momina Khan; Chandra Baker; Robert G Gourdie; James W Smyth; Morten S Nielsen; Steven Poelzing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

4.  Acidosis differentially modulates inactivation in na(v)1.2, na(v)1.4, and na(v)1.5 channels.

Authors:  Yury Y Vilin; Colin H Peters; Peter C Ruben
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

5.  Type 2 Diabetes Induces Prolonged P-wave Duration without Left Atrial Enlargement.

Authors:  Bin Li; Yilong Pan; Xiaodong Li
Journal:  J Korean Med Sci       Date:  2016-03-03       Impact factor: 2.153

Review 6.  Cerebral-Cardiac Syndrome and Diabetes: Cardiac Damage After Ischemic Stroke in Diabetic State.

Authors:  Hong-Bin Lin; Feng-Xian Li; Jin-Yu Zhang; Zhi-Jian You; Shi-Yuan Xu; Wen-Bin Liang; Hong-Fei Zhang
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.